IRIS Accounts Production v24.3.2.46 05833629 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh058336292023-06-30058336292024-06-30058336292023-07-012024-06-30058336292022-06-30058336292022-07-012023-06-30058336292023-06-3005833629ns15:EnglandWales2023-07-012024-06-3005833629ns14:PoundSterling2023-07-012024-06-3005833629ns10:Director12023-07-012024-06-3005833629ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3005833629ns10:SmallEntities2023-07-012024-06-3005833629ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3005833629ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3005833629ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3005833629ns10:FullAccounts2023-07-012024-06-3005833629ns10:Director22023-07-012024-06-3005833629ns10:RegisteredOffice2023-07-012024-06-3005833629ns5:CurrentFinancialInstruments2024-06-3005833629ns5:CurrentFinancialInstruments2023-06-3005833629ns5:ShareCapital2024-06-3005833629ns5:ShareCapital2023-06-3005833629ns5:RetainedEarningsAccumulatedLosses2024-06-3005833629ns5:RetainedEarningsAccumulatedLosses2023-06-3005833629ns5:PlantMachinery2023-06-3005833629ns5:ComputerEquipment2023-06-3005833629ns5:PlantMachinery2023-07-012024-06-3005833629ns5:ComputerEquipment2023-07-012024-06-3005833629ns5:PlantMachinery2024-06-3005833629ns5:ComputerEquipment2024-06-3005833629ns5:PlantMachinery2023-06-3005833629ns5:ComputerEquipment2023-06-3005833629ns5:CostValuation2023-06-3005833629ns5:AdditionsToInvestments2024-06-3005833629ns5:DisposalsRepaymentsInvestments2024-06-3005833629ns5:CostValuation2024-06-3005833629ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3005833629ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-30058336291ns10:Director12023-06-30058336291ns10:Director12022-06-30058336291ns10:Director12023-07-012024-06-30058336291ns10:Director12022-07-012023-06-30058336291ns10:Director12024-06-30058336291ns10:Director12023-06-30
REGISTERED NUMBER: 05833629 (England and Wales)







UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2024

FOR

NATIONWIDE MEDICAL LIMITED

NATIONWIDE MEDICAL LIMITED (REGISTERED NUMBER: 05833629)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


NATIONWIDE MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2024







DIRECTORS: Professor R J Schilling
Mrs C E Schilling





REGISTERED OFFICE: c/o Professor Schilling
5 Frank Dixon Close
London
SE21 7BD





REGISTERED NUMBER: 05833629 (England and Wales)





ACCOUNTANTS: Sandison Easson & Co
Rex Buildings
Alderley Road
Wilmslow
Cheshire
SK9 1HY

NATIONWIDE MEDICAL LIMITED (REGISTERED NUMBER: 05833629)

BALANCE SHEET
30 JUNE 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - 130
Investments 5 505,295 383,469
505,295 383,599

CURRENT ASSETS
Debtors 6 255,429 348,832
Cash at bank 853,545 376,336
1,108,974 725,168
CREDITORS
Amounts falling due within one year 7 133,979 120,452
NET CURRENT ASSETS 974,995 604,716
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,480,290

988,315

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,480,190 988,215
1,480,290 988,315

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

NATIONWIDE MEDICAL LIMITED (REGISTERED NUMBER: 05833629)

BALANCE SHEET - continued
30 JUNE 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2024 and were signed on its behalf by:





Professor R J Schilling - Director


NATIONWIDE MEDICAL LIMITED (REGISTERED NUMBER: 05833629)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1. STATUTORY INFORMATION

Nationwide Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

RELATED PARTY EXEMPTION
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

TURNOVER
The turnover shown in the profit and loss account represents amount earned during the year and is recognised when the company obtains the right to consideration.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Plant and machinery - 25% Straight line
Computer equipment - 25% Straight line

All fixed assets are initially recorded at cost.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

NATIONWIDE MEDICAL LIMITED (REGISTERED NUMBER: 05833629)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 July 2023
and 30 June 2024 25,945 2,144 28,089
DEPRECIATION
At 1 July 2023 25,945 2,014 27,959
Charge for year - 130 130
At 30 June 2024 25,945 2,144 28,089
NET BOOK VALUE
At 30 June 2024 - - -
At 30 June 2023 - 130 130

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 July 2023 383,469
Additions 199,990
Disposals (78,164 )
At 30 June 2024 505,295
NET BOOK VALUE
At 30 June 2024 505,295
At 30 June 2023 383,469

NATIONWIDE MEDICAL LIMITED (REGISTERED NUMBER: 05833629)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 23,785 37,965
Other debtors 45,580 45,580
Other Loans 186,064 260,177
Directors' current accounts - 5,110
255,429 348,832

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Tax 121,810 113,600
PAYE and national insurance 1,749 1,780
Other creditors - 142
Credit Card 5,161 100
Directors' current accounts 72 -
Accrued expenses 5,187 4,830
133,979 120,452

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 June 2024 and 30 June 2023:

2024 2023
£    £   
Professor R J Schilling
Balance outstanding at start of year 5,110 -
Amounts advanced - 5,110
Amounts repaid (5,110 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 5,110